Price of Cancer Drugs Rises After Launch, Unfazed by Market

The cost of oncology drugs, with few exceptions, continues to increase after they enter the market, and in the absence of any tangible reasons for the increase.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply